Our top pick for
FS KKR Capital Corp is an asset management business based in the US. FS KKR Capital shares (FSK) are listed on the NYSE and all prices are listed in US Dollars.
|Latest market close||$22.87|
|52-week range||$12.66 - $23.24|
|50-day moving average||$22.69|
|200-day moving average||$21.79|
|Wall St. target price||$23.06|
|Dividend yield||$2.4 (10.5%)|
|Earnings per share (TTM)||$10.86|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||-1.12%|
|1 month (2021-09-20)||5.15%|
|3 months (2021-07-20)||8.96%|
|6 months (2021-04-20)||12.60%|
|1 year (2020-10-20)||47.07%|
|2 years (2019-10-18)||294.99%|
|3 years (2018-10-19)||243.39%|
|5 years (2016-10-20)||147.24%|
Valuing FS KKR Capital stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FS KKR Capital's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
FS KKR Capital's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, FS KKR Capital shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$667 million|
|Operating margin TTM||79.46%|
|Gross profit TTM||$639 million|
|Return on assets TTM||2.92%|
|Return on equity TTM||26.88%|
|Market capitalisation||$6.5 billion|
TTM: trailing 12 months
There are currently 1.4 million FS KKR Capital shares held short by investors – that's known as FS KKR Capital's "short interest". This figure is 3.7% up from 1.3 million last month.
There are a few different ways that this level of interest in shorting FS KKR Capital shares can be evaluated.
FS KKR Capital's "short interest ratio" (SIR) is the quantity of FS KKR Capital shares currently shorted divided by the average quantity of FS KKR Capital shares traded daily (recently around 1.2 million). FS KKR Capital's SIR currently stands at 1.12. In other words for every 100,000 FS KKR Capital shares traded daily on the market, roughly 1120 shares are currently held short.
However FS KKR Capital's short interest can also be evaluated against the total number of FS KKR Capital shares, or, against the total number of tradable FS KKR Capital shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case FS KKR Capital's short interest could be expressed as 0% of the outstanding shares (for every 100,000 FS KKR Capital shares in existence, roughly 0 shares are currently held short) or 0.0048% of the tradable shares (for every 100,000 tradable FS KKR Capital shares, roughly 5 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against FS KKR Capital.
Find out more about how you can short FS KKR Capital stock.
Dividend payout ratio: 93.16% of net profits
Recently FS KKR Capital has paid out, on average, around 93.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 11.39% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), FS KKR Capital shareholders could enjoy a 11.39% return on their shares, in the form of dividend payments. In FS KKR Capital's case, that would currently equate to about $2.4 per share.
FS KKR Capital's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
FS KKR Capital's most recent dividend payout was on 3 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 September 2021 (the "ex-dividend date").
FS KKR Capital's shares were split on a 1:4 basis on 15 June 2020. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FS KKR Capital shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for FS KKR Capital shares which in turn could have impacted FS KKR Capital's share price.
Over the last 12 months, FS KKR Capital's shares have ranged in value from as little as $12.6619 up to $23.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while FS KKR Capital's is 1.6423. This would suggest that FS KKR Capital's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
FS KKR Capital Corp. is a business development company specializing in investments in debt securities. It seeks to purchase interests in loans through secondary market transactions or directly from the target companies as primary market investments. It also seeks to invest in first lien senior secured loans, second lien secured loans and, to a lesser extent, subordinated loans, or mezzanine loans. In connection with the debt investments, the firm also receives equity interests such as warrants or options as additional consideration. It also seek to purchase minority interests in the form of common or preferred equity in our target companies, either in conjunction with one of the debt investments or through a co-investment with a financial sponsor. Additionally, on an opportunistic basis, the fund may also invest in corporate bonds and similar debt securities.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.